If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
By Rick Winterson Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge. It has now established its global headquarters on Fan Pier in South ...
Plus: A new non-opioid painkiller, the wave of lawsuits against Trump EOs, a key vote for RFK Jr., a big radiopharma deal and ...
USAID staffers told stay out of D.C. headquarters ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
Vertex Pharmaceuticals Incorporated (Nasdaq ... Patients may report side effects to the FDA at 1-800-FDA-1088. Vertex is a global biotechnology company that invests in scientific innovation to create ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on ...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic ...
Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, held an expanded meeting to discuss the national strategy for accessing pharmaceutical products to global markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results